Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. the ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor
Fujimura, N.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 39(9): 984-992
1979
ISSN/ISBN: 0048-0428
PMID: 514803
Accession: 039582021
PDF emailed within 1 workday: $29.90
Related References
Fujimura, N. 1979: Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. II. Comparison between bone scintigraphy and roentgenographic findings and their assessments Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 39(6): 627-636Fujimura, N. 1978: Detection of bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. I. Incidence of bone metastases from bronchogenic carcinoma and their prognosis Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 38(11): 1054-1063
Bussaka, H.; Fujimura, N.; Yamasaki, K. 1980: Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds Kaku Igaku. Japanese Journal of Nuclear Medicine 17(3): 297-303
Fujimura, N. 1978: Bone metastases from breast cancer as detected by bone scintigraphy with 99mTc-phosphorous compounds Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 38(5): 449-456
Suto, Y.; Tanigawa, N.; Iwamiya, T.; Kato, T.; Endo, K.; Shabana, M.; Ohta, Y. 1993: Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 53(8): 953-959
Suto, Y.; Iwamiya, T.; Tanigawa, N.; Shabana, M.; Ohta, Y. 1994: Clinical experience of 1123I-IMP scintigraphy in detecting vertebral bone metastases of hepatocellular carcinoma : a comparison with bone scintigraphy with 99mTc-MDP Acta Radiologica (1987) 35(2): 159-163
Suto, Y.; Iwamiya, T.; Tanigawa, N.; Shabana, M.; Ohta, Y. 1994: Clinical experience of 123I-IMP scintigraphy in detecting vertebral bone metastases of hepatocellular carcinoma. a comparison with bone scintigraphy with 99mTc-MDP Acta Radiologica 35(2): 159-163
Bussaka, H.; Fujimura, N. 1981: Clinical evaluation of bone metastases from carcinoma of the digestive system by scintigraphy with 99mTc-phosphorous compounds Kaku Igaku. Japanese Journal of Nuclear Medicine 18(5): 591-599
Bussaka, H.; Fujimura, N.; Yamasaki, K. 1980: Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with technetium 99m labeled phosphorus compounds Kaku Igaku 17(3): 297-303
Prior, J.O.; Barghouth, G.; Delaloye, J.F.; Leyvraz, S.; Bischof Delaloye, A. 2003: The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer Nuclear Medicine Communications 24(1): 29-36
Cadiot, G.; Lebtahi, R.; Faraggi, M.; Le Guludec, D.; Mignon, M. 1995: Detection of bone metastases of endocrine tumors Comparison of somatostatin receptor scintigraphy with bone scintigraphy Preliminary results Gastroenterology 108(4 Suppl): A346
Lebtahi, R.; Cadiot, G.; Delahaye, N.; Genin, R.; Daou, D.; Peker, M.C.; Chosidow, D.; Faraggi, M.; Mignon, M.; Le Guludec, D. 1999: Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors : Bone scintigraphy compared with somatostatin receptor scintigraphy The Journal of Nuclear Medicine (1978) 40(10): 1602-1608
Lebtahi, R.; Cadiot, G.; Delahaye, N.; Genin, R.; Daou, D.; Peker, M.C.; Chosidow, D.; Faraggi, M.; Mignon, M.; Le Guludec, D. 1999: Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 40(10): 1602-1608
Kucukalic-Selimovic, E.; Begic, A. 2004: Value of bone scintigraphy for detection and ageing of vertebral fractures in patients with severe osteoporosis and correlation between bone scintigraphy and mineral bone density Medicinski Arhiv 58(6): 343-344
Arvola, S.; Seppänen, M.; Malaspina, S.; Mätzke, S.; Raiko, J.; Timonen, K.L.; Ettala, O.; Jambor, I.; Anttinen, M.; Kuisma, A.; Löyttyniemi, E.; Boström, P.J.; Sohlberg, A.; Noponen, T. 2022: Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer Nuclear Medicine Communications 43(5): 510-517
Reske, S.; Kartsens, J.; Sohn, M.; Glöckner, W.; Buell, U. 1993: Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases Acta Oncologica 32(7-8): 753-761
Odori, T. 1979: Clinical evaluation of tumor scintigraphy with 99mTc-bleomycin. (Part II). Combined studies of tumor scintigraphy with 99mTc-BLM and 67Ga-citrate, bone scintigraphy and angiography in bone and soft tissue tumors Kaku Igaku. Japanese Journal of Nuclear Medicine 16(6): 829-847
Begić, A.; Kucukalić-Selimović, E.; Obralić, N.; Durić, O.; Lacević, N.; Begović, S.; Dzubur-Aganović, M. 2005: Role of bone scintigraphy and tumor marker-Ca 15-3 in detection of bone metastases in patients with breast cancer Bosnian Journal of Basic Medical Sciences 5(1): 23-26
Wakabayashi, H.; Nakajima, K.; Mizokami, A.; Namiki, M.; Inaki, A.; Taki, J.; Kinuya, S. 2013: Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases Annals of Nuclear Medicine 27(9): 802-807
Caglar, M.; Ceylan, E. 2001: Isolated carpal bone metastases from bronchogenic cancer evident on bone scintigraphy Clinical Nuclear Medicine 26(4): 352-353